This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Diabetes Mellitus  • Pregnancy and Breast Feeding  • Prognosis/ Outcomes  • Pediatrics  • Neonatology and Infant Care  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2007;298:613-614.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Chicago—Blood glucose levels in pregnant women that are elevated but still within the normal range can increase risks for newborns that have traditionally been associated with overt gestational diabetes. That was the conclusion of the international Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, presented here at the recent American Diabetes Association's 67th Scientific Sessions.

Experts expect that the study's results could alter diagnostic and treatment practices related to maternal glycemia. "These data show clearly that there are associations between blood sugar levels and outcomes in [pregnant women] whose levels aren't high enough to be called diabetes," said principal investigator Boyd Metzger, MD, of the Northwestern University Feinberg School of Medicine, in Chicago. "Therefore, there's benefit for them to be tested," he said.

ELEVATED RISKS

The 7-year observational HAPO study was designed to assess the association of various levels of glucose intolerance during the third trimester of pregnancy with . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Counterpoint: Oral Hypoglyemic Agents Should Be Used to Treat Diabetic Pregnant Women
Coetzee
Diabetes Care 2007;30:2980-2982.
FULL TEXT